Hem › Autoimmuna sjukdomar › North Carolina › Durham
Kliniska studier för Autoimmuna sjukdomar i Durham, NC
15 studier för Autoimmuna sjukdomar söker deltagare vid platser i och runt Durham (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Environmental Risk Factors for the Anti-synthetase Syndrome
RekryterarObservationsstudieFriska volontärer välkomna
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi bort
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekryterarFas 3
- Duke University Hospital, Durham
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RekryterarFas 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 10 mi bort
Daratumumab in Primary Antiphospholipid Syndrome
RekryterarFas 1/2
- Duke University, Durham
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RekryterarFas 1
- Duke University Medical Center, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekryterarFas 3
- Duke University Hospital, Durham
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RekryterarFas 3
- GSK Investigational Site, Durham
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RekryterarFas 1/2
- UNC Chapel Hill, Chapel Hill · 10 mi bort
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekryterarFas 2/3
- Duke University, Durham
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
RekryterarFas 3
- Duke University Medical Center, Durham
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RekryterarFas 3
- Site Number - 1013, Durham
- Site Number - 1020, Chapel Hill · 10 mi bort
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RekryterarFas 1
- Duke University, Durham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi bort
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RekryterarFas 1
- Duke University Health System, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
RekryterarObservationsstudieFriska volontärer välkomna
- Duke University, Durham
Autoimmuna sjukdomar-studier i andra städer
- Houston, TX21 studier
- Washington, DC19 studier
- New York City, NY19 studier
- Philadelphia, PA16 studier
- Boston, MA13 studier
- Los Angeles, CA12 studier
- Chicago, IL12 studier
- Dallas, TX9 studier
- Cleveland, OH8 studier
- Atlanta, GA8 studier
- Milwaukee, WI8 studier
- Portland, OR8 studier
Andra studier i Durham
- Bröstcancer63 studier
- Cancer (alla typer)58 studier
- Icke-småcellig lungcancer39 studier
- Multipelt myelom37 studier
- Metastaserande cancer33 studier
- Akut myeloid leukemi33 studier
- Lungcancer32 studier
- Prostatacancer32 studier
- Kolorektal cancer28 studier
- Kronisk lymfatisk leukemi27 studier
- Äggstockscancer27 studier
- Hjärtsvikt26 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.